Press Releases

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced that the U.S. government has secured 100 million doses of mRNA-1273 as part of the U.S....

Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, announced that it will introduce a 400 mg version of oral antiviral FabiFlu®, for the treatment of mild to moderate COVID-19 in India. The higher strength will improve patient compliance and...

Cherwell Laboratories, specialist suppliers of environmental monitoring and process validation solutions for the pharmaceutical and related industries, has launched a Redipor® prepared media distributor resource centre website. Developing this new online knowledge hub supports Cherwell’s growing international distribution network...

Johnson & Johnson announced its Janssen Pharmaceutical Companies have entered into an agreement with the U.S. government for the large scale domestic manufacturing and delivery in the U.S. of 100 million doses of Janssen’s SARS-CoV-2 investigational vaccine, Ad26.COV2.S, for...

Zydus Cadila, an innovation driven global pharmaceutical company focused on discovering and developing NCEs, Novel Biologicals, Biosimilars and Vaccines, announced that its plasmid DNA vaccine to prevent COVID-19, ZyCoV-D was found to be safe and well tolerated in the...

Sun Pharmaceutical Industries Limited announced that it has launched FluGuard (Favipiravir 200 mg) at an economical price of Rs. 35 per tablet, for the treatment of mild to moderate cases of Covid-19 in India. Favipiravir is the only oral anti-viral...

Cryoport, Inc., a global leader in life sciences supply chain solutions, and MEDIPAL HOLDINGS CORPORATION, Japan's leading pharma wholesaler and distributor announced a multi-year strategic business alliance agreement to create an integrated regenerative medicine supply chain solution in Japan. Cryoport...